Invirsa
Edit

Invirsa

http://invirsa.com/
Last activity: 15.06.2023
Categories: Own
Invirsa's lead compound, INV-102, is derived from a naturally occurring molecule that combats viral conjunctivitis (viral pinkeye) by enhancing the body's own ability to fight the disease.
Website visits
1.7K /mo.
Mentions
6
Location: United States, Ohio, Columbus
Employees: 1-10
Total raised: $8.22M

Investors 2

Funding Rounds 2

DateSeriesAmountInvestors
15.06.2023Series B$7.7MRev1 Ventu...
07.11.2017Seed$520K-

Mentions in press and media 6

DateTitleDescriptionSource
15.06.2023Invirsa Closes $7.7M Series B FinancingInvirsa, a Columbus, OH-based clinical-stage pharmaceutical company, raised $7.7M in Series B fundin...finsmes.co...
15.06.2023CincyTech leads $7.7M round for Columbus-based pharma startu...-bizjournal...
14.06.2023Invirsa Completes $7.7M Series B Financing COLUMBUS, OH, Invirsa, a privately held, clinical-stage pharmaceutical company, announced the clos...vcnewsdail...
07.11.2017Invirsa Secures $520K in Seed FundingInvirsa, a Columbus, Ohio-based pharmaceutical company developing a new line of attack against commo...finsmes.co...
-Invirsa-fastfounde...
-Invirsa: Clinical-Stage Pharmaceutical Company Secures $7.7 ...Invirsa – a privately held, clinical-stage pharmaceutical company focused on developing an innovativ...pulse2.com...

Reviews 0

Sign up to leave a review

Sign up Log In